Literature DB >> 19131262

Invasive group B streptococcal infections in a tertiary care hospital between 1998 and 2007 in Japan.

Kousaku Matsubara1, Go Yamamoto.   

Abstract

OBJECTIVE: To clarify clinical and microbiological features of invasive group B Streptococcus (GBS) disease in Japan.
METHODS: This was a retrospective review for the period 1998-2007 of patients across all age groups in Nishi-Kobe Medical Center. Invasive GBS disease was defined as GBS isolation from a normally sterile site or skin/soft tissues.
RESULTS: Six infant and 52 adult cases of invasive infection were identified. Diagnosis was limited to bacteremia and meningitis in infants, but varied widely in adults with skin/soft tissue infections and bacteremia being common. The overall fatality rate was 16%. An approximately 2.8-fold increase was found in the incidence among adult patients from the first to the second 5-year period. The most frequent underlying condition was diabetes, with the majority (18/23) of such patients showing poor control (HbA1c >8.0%). Amputation at the knee, ankle, or toes was performed in six diabetic adults with skin/soft tissue infections. Of the strains serotyped, types Ib and III predominated. All 58 strains were susceptible to penicillin; 2% were resistant to erythromycin and 3% were resistant to clindamycin.
CONCLUSION: This is the first epidemiological report describing invasive GBS disease in Japan. A significant increase in adult patients was noted, and mortality and morbidity remain substantial.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131262     DOI: 10.1016/j.ijid.2008.10.007

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  10 in total

1.  Insulin modulates the inflammatory granulocyte response to streptococci via phosphatidylinositol 3-kinase.

Authors:  Sybille Kenzel; Miriam Mergen; Julius von Süßkind-Schwendi; Julia Wennekamp; Sachin D Deshmukh; Monika Haeffner; Antigoni Triantafyllopoulou; Sebastian Fuchs; Susan Farmand; Sandra Santos-Sierra; Jochen Seufert; Timo K van den Berg; Taco W Kuijpers; Philipp Henneke
Journal:  J Immunol       Date:  2012-09-26       Impact factor: 5.422

2.  Genomic Traits Associated with Virulence and Antimicrobial Resistance of Invasive Group B Streptococcus Isolates with Reduced Penicillin Susceptibility from Elderly Adults.

Authors:  Shota Koide; Yukiko Nagano; Shino Takizawa; Kanae Sakaguchi; Eiji Soga; Wataru Hayashi; Mizuki Tanabe; Tomohiro Denda; Kouji Kimura; Yoshichika Arakawa; Noriyuki Nagano
Journal:  Microbiol Spectr       Date:  2022-05-31

3.  Invasive group B streptococcal infection in a patient with post splenectomy for hypersplenism secondary to liver cirrhosis and portal hypertension.

Authors:  Tomoya Okazaki; Toru Hifumi; Arisa Manabe; Hikari Matsumura; Satoshi Egawa; Hideyuki Hamaya; Nastuyo Shinohara; Koshiro Takano; Hajime Shishido; Yuko Abe; Kenya Kawakita; Masanobu Hagiike; Yasuhiro Kuroda
Journal:  World J Emerg Med       Date:  2016

Review 4.  Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.

Authors:  Miwako Kobayashi; Johan Vekemans; Carol J Baker; Adam J Ratner; Kirsty Le Doare; Stephanie J Schrag
Journal:  F1000Res       Date:  2016-09-22

5.  Incidence of invasive Group B Streptococcus (iGBS) infections and the factors associated with iGBS mortality in adults during 2013-2017: a retrospective study at Thailand's largest national tertiary referral center.

Authors:  Pakpoom Phoompoung; Nantaporn Pirogard; Amornrut Leelaporn; Nasikarn Angkasekwinai
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

6.  Streptococcus agalactiae in adults at Chiang Mai University Hospital: a retrospective study.

Authors:  Romanee Chaiwarith; Waree Jullaket; Manasanant Bunchoo; Nontakan Nuntachit; Thira Sirisanthana; Khuanchai Supparatpinyo
Journal:  BMC Infect Dis       Date:  2011-05-25       Impact factor: 3.090

Review 7.  Interaction of Streptococcus agalactiae and Cellular Innate Immunity in Colonization and Disease.

Authors:  Sybille Landwehr-Kenzel; Philipp Henneke
Journal:  Front Immunol       Date:  2014-10-29       Impact factor: 7.561

8.  Molecular Characterization of Hospital- and Community-Acquired Streptococcus agalactiae Isolates among Nonpregnant Adults in Isfahan, Iran.

Authors:  Tahereh Motallebirad; Hossein Fazeli; Saba Jalalifar; Darioush Shokri; Sharareh Moghim; Bahram Nasr Esfahani
Journal:  Adv Biomed Res       Date:  2020-09-30

Review 9.  Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses.

Authors:  Lola Madrid; Anna C Seale; Maya Kohli-Lynch; Karen M Edmond; Joy E Lawn; Paul T Heath; Shabir A Madhi; Carol J Baker; Linda Bartlett; Clare Cutland; Michael G Gravett; Margaret Ip; Kirsty Le Doare; Craig E Rubens; Samir K Saha; Ajoke Sobanjo-Ter Meulen; Johan Vekemans; Stephanie Schrag
Journal:  Clin Infect Dis       Date:  2017-11-06       Impact factor: 20.999

10.  Invasive Group B Streptococcal Infection with Toxic Shock-Like Syndrome in a Postsplenectomy Patient.

Authors:  Pradeep Kumar Mada; Gabriel Castano; Andrew Stevenson Joel Chandranesan
Journal:  Case Rep Infect Dis       Date:  2020-02-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.